NorrDia Further Enhances Renal and Acute Therapies Portfolio with agreement to acquire Bellco
NorrDia and its affiliated companies have signed an agreement to acquire Bellco’s global Renal In-Center and Adult Acute Care businesses from Mozarc Medical.
This acquisition strengthens NorrDia’s acute and chronic renal therapy portfolio and expands its global presence.
The transaction is expected to close in Q2 2026, after which NorrDia will integrate Bellco’s operations in Italy, France, and China, as well as its worldwide commercial activities.
The NorrDia team collected long-term successful track records of offering Continuous Renal Replacement Therapies and Hemodialysis Products. Our in-depth expertise has been acquired through Nikkiso Medical, Gambro, Baxter and other leading players in the renal industry. Our board portfolio and clinical experience in combination with the strong focus on simplicity, reliability and affordability, provide professionals with the advanced solution to save and sustain patient's life.
More than
years' experience in Renal Care
More than
CRRT monitors installed base worldwide
More than
countries globally
The NorrDia Portfolio
Discover our innovative products to help you provide quality of care to acute and chronic patients
Introducing Aquarius+
Explore the Aquarius+ key features and see how our technology helps you providing quality of care.
Watch video
